Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Safety and efficacy of recombinant human bone morphogenetic protein 2 on cranial defect closure in the pediatric population.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Safety and efficacy of recombinant human bone morphogenetic protein 2 on cranial defect closure in the pediatric population.
Safety and efficacy of recombinant human bone morphogenetic protein 2 on cranial defect closure in the pediatric population. J Craniofac Surg. 2013 May; 24(3):917-22.
View in:
PubMed
subject areas
Absorbable Implants
Absorbable Implants
Adolescent
Adolescent
Autografts
Autografts
Bone Diseases
Bone Diseases
Bone Morphogenetic Protein 2
Bone Morphogenetic Protein 2
Bone Transplantation
Bone Transplantation
Child
Child
Child, Preschool
Child, Preschool
Collagen
Collagen
Drug Carriers
Drug Carriers
Female
Female
Follow-Up Studies
Follow-Up Studies
Frontal Bone
Frontal Bone
Humans
Humans
Male
Male
Occipital Bone
Occipital Bone
Parietal Bone
Parietal Bone
Recombinant Proteins
Recombinant Proteins
Reconstructive Surgical Procedures
Reconstructive Surgical Procedures
Retrospective Studies
Retrospective Studies
Safety
Safety
Skull
Skull
Tomography, X-Ray Computed
Tomography, X-Ray Computed
Transforming Growth Factor beta
Transforming Growth Factor beta
Treatment Outcome
Treatment Outcome
authors with profiles
Christian A El Amm